Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990)
- PMID: 1559895
Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990)
Abstract
Appendicular osteosarcoma was diagnosed in 30 dogs. Fifteen dogs were treated by limb amputation alone, and 15 dogs were treated by limb amputation followed by 2 doses of cisplatin given IV approximately 2 and 7 weeks after limb removal. Mean survival time after limb amputation alone +/- SD was 190 +/- 138 days (median, 168 days); 7 dogs survived longer than 6 months, and 3 dogs survived more than 1 year. Fourteen of 15 dogs treated by amputation and administration of cisplatin survived a mean of 315 +/- 158 days (median, 290 days) after amputation, and 1 dog was still alive at 1,095 days; 13 dogs survived longer than 6 months and 5 dogs survived more than 1 year. Survival time was significantly (P less than 0.05) greater in dogs given cisplatin.
Similar articles
-
Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990).J Am Vet Med Assoc. 1992 Jun 15;200(12):2005-8. J Am Vet Med Assoc. 1992. PMID: 1639715
-
Use of cisplatin for treatment of appendicular osteosarcoma in dogs.J Am Vet Med Assoc. 1988 Feb 15;192(4):507-11. J Am Vet Med Assoc. 1988. PMID: 3163684
-
Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin.J Vet Intern Med. 1988 Oct-Dec;2(4):177-80. doi: 10.1111/j.1939-1676.1988.tb00313.x. J Vet Intern Med. 1988. PMID: 3230557
-
Canine osteosarcoma: amputation and chemoimmunotherapy.Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):123-33. doi: 10.1016/s0195-5616(96)50011-2. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825571 Review.
-
Canine osteosarcoma: amputation and chemotherapy.Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):111-21. doi: 10.1016/s0195-5616(96)50010-0. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825570 Review.
Cited by
-
The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.Can J Vet Res. 2017 Jul;81(3):199-205. Can J Vet Res. 2017. PMID: 28725110 Free PMC article. Clinical Trial.
-
Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.J Vet Intern Med. 2017 Jul;31(4):1159-1162. doi: 10.1111/jvim.14724. Epub 2017 May 15. J Vet Intern Med. 2017. PMID: 28503759 Free PMC article.
-
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics.Acta Vet Scand. 2017 Oct 24;59(1):71. doi: 10.1186/s13028-017-0341-9. Acta Vet Scand. 2017. PMID: 29065898 Free PMC article. Review.
-
Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.Vet Comp Oncol. 2025 Jun;23(2):161-167. doi: 10.1111/vco.13041. Epub 2025 Jan 11. Vet Comp Oncol. 2025. PMID: 39797571 Free PMC article.
-
Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):197-206. doi: 10.1089/jamp.2009.0773. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 19803732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical